• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低 ETV1 mRNA 表达与胃肠道间质瘤的复发相关。

Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.

机构信息

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.

Department of Gastroenterology, Fujita Health University School of Medicine, 1-98 Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.

出版信息

Sci Rep. 2020 Sep 8;10(1):14767. doi: 10.1038/s41598-020-71719-y.

DOI:10.1038/s41598-020-71719-y
PMID:32901065
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7478956/
Abstract

Although the majority of gastrointestinal stromal tumors (GISTs) possess KIT mutations that induce constitutive signal transduction, the clinical outcomes are variable. The ETS translocation variant 1 (ETV1) gene encodes a transcription factor that is reported to cooperate with KIT in GISTs. However, the clinical role of ETV1 is largely unknown. The aim of this study was to examine ETV1 expression and its associations with clinical features in GISTs. We conducted a cohort study involving 64 patients with GISTs who underwent surgical resection between October 2008 and February 2015. ETV1 mRNA expression was compared with that in non-GISTs and was analyzed among risk classifications or clinical outcomes. The GIST samples exhibited significantly higher ETV1 mRNA expression than the non-GIST samples (P < 0.0001). Sixty-four GISTs were stratified into high or low ETV1 mRNA expression groups based on the median relative abundance of ETV1 mRNA. The multivariate analysis showed that low ETV1 expression, as well as tumor size and mitotic index, was an independent factor of recurrence (hazard ratio: 8.1). Patients with high ETV1 expression achieved significantly longer recurrence-free survival (RFS) times than those with low ETV1 expression (P = 0.025). Our study revealed that low ETV1 expression is an independent factor of recurrence after surgery in patients with GISTs, and thus, low ETV1 expression might be a marker of more aggressive malignant GISTs.

摘要

虽然大多数胃肠道间质瘤(GIST)具有诱导组成性信号转导的 KIT 突变,但临床结果是可变的。ETS 易位变体 1(ETV1)基因编码一种转录因子,据报道该转录因子与 GIST 中的 KIT 合作。然而,ETV1 的临床作用在很大程度上是未知的。本研究旨在研究 ETV1 表达及其与 GIST 临床特征的关系。我们进行了一项队列研究,纳入了 2008 年 10 月至 2015 年 2 月间接受手术切除的 64 例 GIST 患者。比较了 ETV1 mRNA 表达与非 GISTs 的表达,并在风险分类或临床结果中进行了分析。GIST 样本的 ETV1 mRNA 表达明显高于非 GIST 样本(P<0.0001)。根据 ETV1 mRNA 的中位数相对丰度,将 64 例 GIST 分为高或低 ETV1 mRNA 表达组。多变量分析显示,低 ETV1 表达以及肿瘤大小和有丝分裂指数是复发的独立因素(风险比:8.1)。高 ETV1 表达的患者无复发生存时间明显长于低 ETV1 表达的患者(P=0.025)。我们的研究表明,低 ETV1 表达是 GIST 患者手术后复发的独立因素,因此,低 ETV1 表达可能是侵袭性恶性 GIST 的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/fb5f3202a5af/41598_2020_71719_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/3a2da52994b1/41598_2020_71719_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/1c14e35e0500/41598_2020_71719_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/fb5f3202a5af/41598_2020_71719_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/3a2da52994b1/41598_2020_71719_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/1c14e35e0500/41598_2020_71719_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94f8/7478956/fb5f3202a5af/41598_2020_71719_Fig3_HTML.jpg

相似文献

1
Low ETV1 mRNA expression is associated with recurrence in gastrointestinal stromal tumors.低 ETV1 mRNA 表达与胃肠道间质瘤的复发相关。
Sci Rep. 2020 Sep 8;10(1):14767. doi: 10.1038/s41598-020-71719-y.
2
Altered expression of ETV1 and its contribution to tumorigenic phenotypes in gastrointestinal stromal tumors.ETV1的表达改变及其在胃肠道间质瘤致瘤表型中的作用
Oncol Rep. 2014 Sep;32(3):927-34. doi: 10.3892/or.2014.3281. Epub 2014 Jun 23.
3
Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors.鉴定载脂蛋白受体 A 类结构域包含蛋白 4(LDLRAD4)作为原发性胃肠间质瘤的预后指标。
Curr Probl Cancer. 2020 Dec;44(6):100593. doi: 10.1016/j.currproblcancer.2020.100593. Epub 2020 May 27.
4
ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.ETV1信使核糖核酸在胃肠道间质瘤中特异性表达。
Virchows Arch. 2015 Oct;467(4):393-403. doi: 10.1007/s00428-015-1813-9. Epub 2015 Aug 5.
5
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.ETV1 是一种谱系存活因子,与 KIT 在胃肠道间质肿瘤中协同作用。
Nature. 2010 Oct 14;467(7317):849-53. doi: 10.1038/nature09409. Epub 2010 Oct 3.
6
MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1.丝裂原活化蛋白激酶激活蛋白激酶 2 过表达影响胃肠道间质瘤的预后,并与 1 号染色体上的拷贝数变异以及 p38MAP 激酶和 ETV1 的表达相关。
Clin Cancer Res. 2012 Apr 1;18(7):1879-87. doi: 10.1158/1078-0432.CCR-11-2364. Epub 2012 Feb 20.
7
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.血小板衍生生长因子受体-α通过稳定ETV1来调节KIT基因发生突变的胃肠道间质瘤细胞的增殖。
Gastroenterology. 2015 Aug;149(2):420-32.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9.
8
Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.利用连接图谱鉴定吩噻嗪类药物是胃肠道间质瘤中的一个 ETV1 靶向治疗剂。
Int J Oncol. 2019 Aug;55(2):536-546. doi: 10.3892/ijo.2019.4829. Epub 2019 Jun 21.
9
Differential Expression of in Gastrointestinal Stromal Tumors of Different Sites and with Different Gene Abnormalities.在不同部位和具有不同基因突变的胃肠道间质瘤中 的差异表达。
Pathol Oncol Res. 2021 Apr 19;27:602008. doi: 10.3389/pore.2021.602008. eCollection 2021.
10
Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumors.在胃肠道间质瘤中,CIC 的下调与 ETV1 的过表达或 MAP 激酶通路的激活无关。
Cancer Invest. 2014 Aug;32(7):363-7. doi: 10.3109/07357907.2014.919304. Epub 2014 Jun 4.

引用本文的文献

1
Advances in the diagnosis and treatment of MET-variant digestive tract tumors.MET变异型消化道肿瘤的诊断与治疗进展
World J Gastrointest Oncol. 2024 Nov 15;16(11):4338-4353. doi: 10.4251/wjgo.v16.i11.4338.
2
Improved understanding of gastrointestinal stromal tumors biology as a step for developing new diagnostic and therapeutic schemes.加深对胃肠道间质瘤生物学的理解,作为开发新诊断和治疗方案的一个步骤。
Oncol Lett. 2021 May;21(5):417. doi: 10.3892/ol.2021.12678. Epub 2021 Mar 28.

本文引用的文献

1
Identification of phenothiazine as an ETV1‑targeting agent in gastrointestinal stromal tumors using the Connectivity Map.利用连接图谱鉴定吩噻嗪类药物是胃肠道间质瘤中的一个 ETV1 靶向治疗剂。
Int J Oncol. 2019 Aug;55(2):536-546. doi: 10.3892/ijo.2019.4829. Epub 2019 Jun 21.
2
Clinical and pathological features of "small" GIST (≤2 cm). What is their prognostic value?“小”GIST(≤2cm)的临床和病理特征。它们的预后价值如何?
Eur J Surg Oncol. 2018 May;44(5):580-586. doi: 10.1016/j.ejso.2018.01.087. Epub 2018 Feb 5.
3
ETV4 collaborates with Wnt/β-catenin signaling to alter cell cycle activity and promote tumor aggressiveness in gastrointestinal stromal tumor.
ETV4与Wnt/β-连环蛋白信号通路协同作用,改变细胞周期活性并促进胃肠道间质瘤的肿瘤侵袭性。
Oncotarget. 2017 Dec 11;8(69):114195-114209. doi: 10.18632/oncotarget.23173. eCollection 2017 Dec 26.
4
KIT Exon 11 Codons 557-558 Deletion Mutation Promotes Liver Metastasis Through the CXCL12/CXCR4 Axis in Gastrointestinal Stromal Tumors.KIT 外显子 11 密码子 557-558 缺失突变通过 CXCL12/CXCR4 轴促进胃肠道间质瘤肝转移。
Clin Cancer Res. 2016 Jul 15;22(14):3477-87. doi: 10.1158/1078-0432.CCR-15-2748. Epub 2016 Mar 2.
5
ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.ETV1信使核糖核酸在胃肠道间质瘤中特异性表达。
Virchows Arch. 2015 Oct;467(4):393-403. doi: 10.1007/s00428-015-1813-9. Epub 2015 Aug 5.
6
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.血小板衍生生长因子受体-α通过稳定ETV1来调节KIT基因发生突变的胃肠道间质瘤细胞的增殖。
Gastroenterology. 2015 Aug;149(2):420-32.e16. doi: 10.1053/j.gastro.2015.04.006. Epub 2015 Apr 9.
7
Combined inhibition of MAP kinase and KIT signaling synergistically destabilizes ETV1 and suppresses GIST tumor growth.丝裂原活化蛋白激酶(MAP激酶)和KIT信号传导的联合抑制协同地使ETV1不稳定并抑制胃肠道间质瘤(GIST)肿瘤生长。
Cancer Discov. 2015 Mar;5(3):304-15. doi: 10.1158/2159-8290.CD-14-0985. Epub 2015 Jan 8.
8
Gene expression network analysis of ETV1 reveals KCTD10 as a novel prognostic biomarker in gastrointestinal stromal tumor.ETV1的基因表达网络分析揭示KCTD10是胃肠道间质瘤中的一种新型预后生物标志物。
PLoS One. 2013 Aug 19;8(8):e73896. doi: 10.1371/journal.pone.0073896. eCollection 2013.
9
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del).一组以前被认为是野生型肿瘤的胃肠道间质瘤携带 KIT 外显子 8 中的体细胞激活突变(p.D419del)。
Mod Pathol. 2013 Jul;26(7):1004-12. doi: 10.1038/modpathol.2013.47. Epub 2013 Apr 19.
10
MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1.丝裂原活化蛋白激酶激活蛋白激酶 2 过表达影响胃肠道间质瘤的预后,并与 1 号染色体上的拷贝数变异以及 p38MAP 激酶和 ETV1 的表达相关。
Clin Cancer Res. 2012 Apr 1;18(7):1879-87. doi: 10.1158/1078-0432.CCR-11-2364. Epub 2012 Feb 20.